Literature DB >> 26781040

Downregulation of β3 integrin by miR-30a-5p modulates cell adhesion and invasion by interrupting Erk/Ets‑1 network in triple-negative breast cancer.

Wentong Li1, Chuanliang Liu2, Chunling Zhao3, Limin Zhai1, Shijun Lv1.   

Abstract

Integrins are adhesion receptors involved in bidirectional signaling and are crucial for various cellular responses during normal homeostasis and pathological conditions, such as cancer progression and metastasis. In the present study, we demonstrated that blockage of β3 integrin-mediated cell- extracellular matrix interactions restrained triple-negative breast cancer (TNBC) growth, and elevated β3 integrin can trigger the rewiring of Erk/Ets-1 signaling pathways, thereby enhancing cell growth and invasion. Ectopic expression of miRNA has been implicated in the deregulation of integrin expression and activity, blocking of cancer tumor development and progression, and acquisition of metastatic phenotype. miR-30a-5p expression has been implicated in the progression of breast cancer. Overexpression of miR-30a-5p suppressed the proliferation, migration and invasion of breast cancer cells. On the contrary, inhibition of miR-30a-5p promoted the proliferation, migration, and invasion of TNBC cells by suppressing the expression of ERK/Ets-1 signal. An inverse correlation was found between the mRNA expressions of miR-30a-5p and β3 integrin in TNBC samples. Furthermore, bioinformatics analysis revealed the putative miR-30 binding sites in the 3'-UTR of β3 integrin. Results of luciferase assay revealed a strong repression of luciferase activity after transfection with miR‑30a-5p and wild-type 3'-UTR of β3 integrin. In TNBC cells, miR-30a-5p promoted an epithelial phenotype and suppressed invasion by specifically targeting β3 integrin subunit to subsequently interdict the β3 integrin/Erk/Ets-1 network.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26781040     DOI: 10.3892/ijo.2016.3319

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  21 in total

1.  Immune regulation of miR-30 on the Mycobacterium tuberculosis-induced TLR/MyD88 signaling pathway in THP-1 cells.

Authors:  Yuqing Wu; Qi Sun; Liang Dai
Journal:  Exp Ther Med       Date:  2017-08-02       Impact factor: 2.447

Review 2.  Roles of miRNA and lncRNA in triple-negative breast cancer.

Authors:  Juan Xu; Kang-Jing Wu; Qiao-Jun Jia; Xian-Feng Ding
Journal:  J Zhejiang Univ Sci B       Date:  2020 Sept.       Impact factor: 3.066

3.  Aberrant expression of microRNA induced by high-fructose diet: implications in the pathogenesis of hyperlipidemia and hepatic insulin resistance.

Authors:  Neetu Sud; Hanyuan Zhang; Kaichao Pan; Xiao Cheng; Juan Cui; Qiaozhu Su
Journal:  J Nutr Biochem       Date:  2017-02-20       Impact factor: 6.048

4.  MicroRNAs and Heat Shock Proteins in Breast Cancer Biology.

Authors:  Mehmet Taha Yildiz; Lütfi Tutar; Nazlı Irmak Giritlioğlu; Banu Bayram; Yusuf Tutar
Journal:  Methods Mol Biol       Date:  2022

Review 5.  The functional significance and cross-talk of non-coding RNAs in triple negative and quadruple negative breast cancer.

Authors:  Utpalendu Paul; Satarupa Banerjee
Journal:  Mol Biol Rep       Date:  2022-03-02       Impact factor: 2.742

6.  Integrin αvβ3-associated DAAM1 is essential for collagen-induced invadopodia extension and cell haptotaxis in breast cancer cells.

Authors:  Ting Yan; Ailiang Zhang; Fangfang Shi; Fei Chang; Jie Mei; Yongjian Liu; Yichao Zhu
Journal:  J Biol Chem       Date:  2018-05-11       Impact factor: 5.157

7.  The metastasis suppressor NME1 inhibits melanoma cell motility via direct transcriptional induction of the integrin beta-3 gene.

Authors:  M Kathryn Leonard; Marián Novak; Devin Snyder; Grace Snow; Nidhi Pamidimukkala; Joseph R McCorkle; Xiuwei H Yang; David M Kaetzel
Journal:  Exp Cell Res       Date:  2018-11-17       Impact factor: 3.905

8.  Overexpression of suppressive microRNAs, miR-30a and miR-200c are associated with improved survival of breast cancer patients.

Authors:  Tsutomu Kawaguchi; Li Yan; Qianya Qi; Xuan Peng; Emmanuel M Gabriel; Jessica Young; Song Liu; Kazuaki Takabe
Journal:  Sci Rep       Date:  2017-11-21       Impact factor: 4.379

9.  miR-30a suppresses lung cancer progression by targeting SIRT1.

Authors:  Yaowu Guan; Zhongming Rao; Cheng Chen
Journal:  Oncotarget       Date:  2017-12-21

10.  Identification of MicroRNAs as Breast Cancer Prognosis Markers through the Cancer Genome Atlas.

Authors:  Jeremy T-H Chang; Fan Wang; William Chapin; R Stephanie Huang
Journal:  PLoS One       Date:  2016-12-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.